SCHEMBL7572129

SCHEMBL7572129

N#Cc1ccc(S(=O)(=O)Nc2cc3ccccc3cc2NS(=O)(=O)c2ccc(C#N)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 1/20 0.60
KDM4E B2RXH2 1/20 0.59
STAT3 P40763 1/20 0.56
ACLY P53396 1/20 0.56
HSD11B1 P28845 5/20 0.56
CYP19A1 P11511 2/20 0.54
AR P10275 1/20 0.52
SLC22A12 Q96S37 2/20 0.51
BRD1 O95696 2/20 0.51
BRPF1 P55201 2/20 0.51
BRPF3 Q9ULD4 2/20 0.51
BRD9 Q9H8M2 1/20 0.51
ATIC P31939 2/20 0.50
KAT6A Q92794 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28316252 0.83 LMNA (0.69) KDM4EHSD11B1CYP19A1ARBRD1
SCHEMBL7571206 0.83 RECQL (0.69) GLO1KDM4ESTAT3ACLYHSD11B1
SCHEMBL7577515 0.81 SMN1; SMN2 (0.65) GLO1
SCHEMBL7589336 0.81 SLC22A12 (0.54) GLO1STAT3ACLYCYP19A1SLC22A12
SCHEMBL12230253 0.80 ATM (0.67) KDM4ECYP19A1ARBRD1BRPF1
SCHEMBL14645850 0.79 ALDH1A1 (0.65) GLO1KDM4ESTAT3ACLYHSD11B1
SCHEMBL16592703 0.79 TSHR (0.65) GLO1KDM4ESTAT3ACLYHSD11B1
SCHEMBL7595509 0.78 SLC22A12 (0.56) GLO1ACLYHSD11B1SLC22A12ATIC
SCHEMBL14645822 0.78 CYP19A1 (0.75) KDM4EHSD11B1CYP19A1ARSLC22A12
SCHEMBL7571483 0.78 LMNA (0.67) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1239852-A2 BISSULFONAMIDE DERIVATIVES AS ENZYME INHIBITORS Arrow Therapeutics Limited (GB) 2002-09-18 EP disclosed
WO-2001028537-A2 BISSULFONAMIDE DERIVATIVES AS ENZYME INHIBITORS ARROW THERAPEUTICS LIMITED (GB) 2001-04-26 WO disclosed